Stocks · Health care · Pharmaceutical Preparations

Entrada Therapeutics, Inc.

TRDA Clue Score28
United States Fiscal year ends December CIK 0001689375 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Kory James Wentworth
3 Apr 2025
Chief Financial Officer
Exercised, kept
11,134
$2.10
$23.38K
Peter S Kim
3 Jun 2024
Director
Exercised, kept
11,918
$6.06
$72.22K
Kory James Wentworth
15 Mar 2024
Chief Financial Officer
Exercised, kept
9,000
$2.10
$18.90K
Kory James Wentworth
29 Jun 2023
Chief Financial Officer
Exercised, kept
8,790
$2.10
$18.46K
Showing 250 of 282 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 215
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 26
Sales on a Rule 10b5-1 plan 62
Sales straight out of an exercise 45
Sales at will 110
Transactions with no price 0
Shares from compensation/vesting 26,064,466
Sales filed before the plan box existed 55
History held since 1 Nov 2021